Skip to main content
Daniel Beckles, MD, Thoracic Surgery, Lake Charles, LA

DanielLincolnBecklesMDPhD, FACS

Thoracic Surgery Lake Charles, LA

Adult Cardiac Surgery, Cardiopulmonary Transplantation, Minimally Invasive Cardiac Surgery, Cardiovascular Surgery

Surgical Director, Heart Transplantation and Mechanical Circulatory Support Baylor S&W Health Cardiovascular Institute Texas

Dr. Beckles is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Beckles' full profile

Already have an account?

  • Office

    401 Dr Michael Debakey Dr
    Lake Charles, LA 70601
    Phone+1 337-513-0100
    Fax+1 337-513-0105

Summary

  • Dr. Daniel L. Beckles is a Cardiothoracic surgeon at Baylor Scott & White Medical Center Temple, Texas and is an affiliated Professor with Texas A&M University. He received his medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 20 years. He specializes in adult cardiac surgery, cardiopulmonary transplantation, minimally invasive cardiac surgery, and cardiovascular surgery and is experienced in heart failure, video-assisted thoracoscopic surgery, esophagectomy, thymectomy, and adult general thoracic surgery.
  • daniel beckles | BSWHealth.med

    Comprehensive Cardiovascular Institute at Baylor Scott & White Health. https://www.bswhealth.med/physician/daniel-beckles

    Home | Center for Cardiac and Metabolic Diseases

    Research (double click left box)

Education & Training

  • Brigham and Women's Hospital/Children's Hospital
    Brigham and Women's Hospital/Children's HospitalFellowship, Thoracic Surgery, 2007 - 2008
  • U Texas SW Med Sch
    U Texas SW Med Sch2004 - 2007
  • SUNY Downstate Health Sciences University
    SUNY Downstate Health Sciences UniversityChief Residency, Surgery, 2003 - 2004
  • SUNY Downstate Medical center
    SUNY Downstate Medical centerPhD, Molecular and Cellular Biology (Cardiovascular), US patents, 1999 - 2004
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 1997
  • SUNY Stony Brook
    SUNY Stony BrookMS, Chemistry (Organic chemisrty-artificial receptor synthesis), Text book chapter, MS Thesis, 1991 - 1994

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2010 - 2025
  • LA State Medical License
    LA State Medical License 2023 - 2024
  • FL State Medical License
    FL State Medical License 2014 - 2022
  • NY State Medical License
    NY State Medical License 2003 - 2020
  • MA State Medical License
    MA State Medical License 2007 - 2008
  • American Board of Surgery Surgery
  • American Board of Thoracic Surgery Thoracic and Cardiac Surgery

Awards, Honors, & Recognition

  • New York Top Doctor Super Doctors, 2016-2017
  • H Texas Magazine Top Docs H Texas Magazine, 2014
  • AOA Alpha Omega Alpha, 2003
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Clinical Data Supports the Role of Ultrafiltration in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI)
    Clinical Data Supports the Role of Ultrafiltration in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI)February 23rd, 2023
  • Nuwellis Announces New Clinical Data Demonstrating 100% Survival at 30 Days Following Use of Ultrafiltration in High-Risk Postoperative Coronary Artery Bypass Grafting (CABG) Patients
    Nuwellis Announces New Clinical Data Demonstrating 100% Survival at 30 Days Following Use of Ultrafiltration in High-Risk Postoperative Coronary Artery Bypass Grafting (CABG) PatientsAugust 31st, 2022
  • Nuwellis (NASDAQ: NUWE) Reports Clinical Data Showing 100% Survival Rate Using Ultrafiltration in High-Risk CABG Patients
    Nuwellis (NASDAQ: NUWE) Reports Clinical Data Showing 100% Survival Rate Using Ultrafiltration in High-Risk CABG PatientsAugust 31st, 2022
  • Join now to see all

Professional Memberships